When five-year-old goldendoodle Mozzi started walking “unnaturally,” his concerned owner rushed him to a vet in South Korea, where the problem was diagnosed not by humans, but by artificial intelligence (AI).
South Korea, a global leader in the production of chips that power generative AI, has been quick to embrace novel uses of the technology.
One such application, “X Caliber,” is helping vets pinpoint X-ray abnormalities in seconds, making diagnostics quicker and easier to explain.
Photo: AFP
The AI reading of Mozzi’s X-rays showed the curly-haired goldendoodle had a 22 percent chance of knee dislocation. While not an emergency, his condition needed careful management to head off surgery.
“I wouldn’t have understood the results if I didn’t look at the numbers,” said Mo Jae-hyun, Mozzi’s owner, adding that the AI program helped him understand his pet’s woes. “Of course, I trust my vet, but looking at the results myself, it seems more credible.”
The software’s developer, South Korean telecom provider SK Telecom, said that X Caliber has a disease detection rate of up to 86 percent.
Vets say it has transformed their ability to diagnose.
“Dogs with heart disease, for example, tend to have enlarged hearts. We use a method called VHS [vertebral heart size], which used to require measuring one by one, manually,” Sky Animal Medical Group chief executive officer Oh I-se said.
However, now AI can reveal the result in 15 seconds, so it is “much more convenient,” Oh said.
SK Telecom considers X Caliber “the beginning of AI healthcare,” said Joo Ye-seul, manager of the software’s global team. “We plan further expansion into additional domains based on this.”
The service is already available in the US, Australia and some Southeast Asian countries.
In Indonesia, veterinary hospital owner Kristanya Oen said that X Caliber is helping to overcome a lack of expertise and trained staff.
“There is a shortage of radiologists in Indonesian animal hospitals and it is not easy to receive radiology education in Indonesia, so we needed X Caliber to help with our diagnostics,” Oen told reporters.
SK Telecom is part of the same conglomerate as SK Hynix, which launched the first high-bandwidth memory chips — cutting-edge semiconductors that enable faster data processing and the more complex tasks of generative AI.
While many experts are questioning the payoff of lavish AI investments following a recent fall in technology stocks, SK Group CEO Chey Tae-won remains committed.
SK Group must “think fiercely about next-generation products,” Chey told employees this month.
In June, SK Group announced plans to invest 80 trillion won (US$60 billion) in AI chips, services and data centers.
In South Korea, where more people are turning to “pet parenthood” instead of having children, it is not necessarily surprising that AI healthcare would begin with animals.
In a country with one of the world’s lowest birthrates, pet ownership has roughly doubled in the past decade, official figures show.
One in four households now have at least one furry friend and last year more strollers were sold for pets than for human babies on the Gmarket e-commerce platform.
The pet care industry was worth an estimated 8 trillion won in 2022, a fourfold increase compared with five years earlier.
The South Korean government aims to double the industry’s value by 2027 and is helping support pet food and healthcare businesses through loans and tax incentives.
Jumping on the trend, South Korean companies are working on new ways of integrating AI into pet care, including “smart toilets” for early detection of urinary diseases and “smart leashes” that monitor pulse and body temperature.
“Devices that can monitor mild to severe diseases in the daily life of pets are expected to expand,” said Kim Soo-kyung, a senior manager at KPMG Korea’s Economic Research Institute.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS